Udenafil
From Self-sufficiency
| File:Udenafil.png | |
| Systematic (IUPAC) name | |
|---|---|
|
3-(1-methyl-7-oxo-3-propyl-4,7-dihydro-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-N-[2-(1-methylpyrrolidin-2-yl)ethyl]-4-propoxybenzenesulfonamide | |
| Pharmacokinetic data | |
| Biological half-life | 7.3–12.1 hours[1] |
| Identifiers | |
| CAS Number | 268203-93-6 |
| ATC code | none |
| PubChem | CID 6918523 |
| Chemical data | |
| Formula | C25H36N6O4S |
| Molar mass | 516.657 g/mol[[Script error: No such module "String".]] |
Udenafil is a drug used in urology to treat erectile dysfunction. It belongs to a class of drugs called PDE5 inhibitor, which many other erectile dysfunction drugs such as sildenafil, tadalafil, and vardenafil also belong to. It was developed by Dong-A Pharmaceutical and is marketed under the trade name Zydena.[2] It is not approved for use in the United States by the U.S. Food and Drug Administration.
References
- ↑ Udenafil Information
- ↑ Zydena (udenafil) product information page. Dong-A Pharmaceutical. Retrieved on April 13, 2009.
| 40px | This drug article relating to the genito-urinary system is a stub. You can help ssf by expanding it. |
Categories:
- Pages with script errors
- Pages with broken file links
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs not assigned an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- 2Fix
- PDE5 inhibitors
- Pyrrolidines
- Sulfonamides
- Lactams
- Phenol ethers
- Pyrazolopyrimidines
- Genito-urinary system drug stubs
